Jpmorgan Chase & Co »

Elicio Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $91 18 5.06

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Elicio Therapeutics

Vanguard Group
Armistice Capital
Geode Capital Management
Arena Investors
CM Management
Northern Trust
State Street Corporation
BlackRock
BlackRock
Meyer Handelman
Citadel Advisors
Bridgeway Capital Management
Atlantic Trust
Steward Partners Investment Advisory
Bank of America Corporation

View all funds holding Elicio Therapeutics